Evidence map›Paper›PMID 40144242›Full record

ArticleJHLT open2024

Heart transplantation with super-aged donors older than 65 years.

Tasuku Hada, Osamu Seguchi, Nana Kitahata, Shotaro Komeyama, Hiroki Mochizuki, Takuya Watanabe, Satoshi Kainuma, Satsuki Fukushima, Yasumasa Tsukamoto, Tomoyuki Fujita and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tasuku HadaDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Osamu SeguchiDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Nana KitahataDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Shotaro KomeyamaDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Hiroki MochizukiDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Takuya WatanabeDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Satoshi KainumaDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Satsuki FukushimaDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Yasumasa TsukamotoDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Tomoyuki FujitaDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Jon KobashigawaDepartment of Cardiology, Cedars-Sinai Smidt Heart Institute, Los Angeles, California.
Norihide FukushimaDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study elucidated the clinical outcomes and serial allograft function of heart transplant (HTx) recipients who received hearts from super-aged donors (SAD) ≥65 years of age. Methods: Adult HTx recipients between 1999 and 2022 were retrospectively reviewed and divided into 2: donor age ≥65 years [SAD group ( Results: Compared with the recipients in the YD group, those in the SAD group were older [age, 60 (interquartile range (IQR): 46-63) vs 42 (IQR: 31-52) years, Conclusion: SAG hearts at ≥65 years can be used for HTx with acceptable outcomes and feasible allograft function in relatively older recipients.

Indexed as

aged donorcardiac functiondonor evaluationdonor selectionheart transplantation

Identifiers

PMID40144242
PMCPMC11935347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.